TCR2 THERAPEUTICS INC.

/TCR2 THERAPEUTICS INC.

We are an innovative immunotherapy company developing the next generation of novel T cell therapies for patients suffering from cancer

Symbol

Price Range
$14.00 - $16.00

Final Shares
5,000,000

Effective Date
February 14, 2019

Underwriters

To view the prospectus for IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange